OrPro Therapeutics, Inc. — Form D
OrPro Therapeutics, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-18. $1.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-12-18
- Form: D
- Accession: 0001140361-13-046725
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $1.3M
- Investors: 12
- Date of first sale: 2013-12-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-208254
Issuer
- Name: OrPro Therapeutics, Inc.
- CIK: 0001594679
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: C/O LATHAM & WATKINS LLP, SAN DIEGO, CA, 92130
- Phone: (858) 353-3630
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Mary Jacqueline Johnson | Director | DEL MAR, CA |
| Cam L Garner | Director | San Diego, CA |
| Cam L Garner | Executive Officer | San Diego, CA |
| Jeffrey W Raser | Director | San Diego, CA |
| James W Weil | Director | San Diego, CA |
| Peter B Heifetz, Ph.D. | Director | San Diego, CA |
| Peter B Heifetz, Ph.D. | Executive Officer | San Diego, CA |
Other filings by this issuer (1)
More